Skip to content

Dossier · BMA · Dormant

BMA · Banco Macro S.A. · Stock research

LOW Compounder Catalyst · emerging-markets

Last analysed ·

Current thesis

Argentina disinflation/credit-recovery basket; BMA is the best-capitalized domestic vehicle. Sequential CPI is genuinely improving (3.4%→2.6%→2.1%→1.9% MoM, Mar–Jun 2026), but the tape has gone nowhere since the Oct-2025 midterm leg — ~$90 vs the $106.15 high, four months mid-range. Cost of risk guided 5.5–6% caps near-term ROE; no company catalyst until the 2026-08-26 Q2 print, so the mid-August CPI release is the only near-term thesis mover.

Invalidation trigger

A weekly close below $78 breaks the post-midterm consolidation base and the rising 200-day line; secondarily, two consecutive INDEC monthly CPI prints re-accelerating MoM, or NPLs above 5.40% with coverage under ~100% at the 2026-08-26 report.

Thesis status

Open commitment catalyst in 15dscored if the trigger above fires How this is scored →

Latest analysis and events for BMA —

As of 2026-07-19, orbyd's latest analysis for Banco Macro S.A. (BMA): Argentina disinflation/credit-recovery basket; BMA is the best-capitalized domestic vehicle. Sequential CPI is genuinely improving (3.4%→2.6%→2.1%→1.9% MoM, Mar–Jun 2026), but the tape has gone nowhere since the Oct-2025 midterm leg — ~$90 vs the $106.15 high, four months mid-range. Cost of risk guided 5.5–6% caps near-term ROE; no company catalyst until the 2026-08-26 Q2 print, so the mid-August CPI release is the only near-term thesis mover.

Invalidation trigger: A weekly close below $78 breaks the post-midterm consolidation base and the rising 200-day line; secondarily, two consecutive INDEC monthly CPI prints re-accelerating MoM, or NPLs above 5.40% with coverage under ~100% at the 2026-08-26 report.

Next dated event on file: — catalyst in 15d.

Current Thesis

The trade is the Argentina disinflation-and-credit-recovery basket, and Banco Macro is the best-capitalized domestic vehicle inside it — interior-province retail and SME lending, the book that re-levers first when real rates fall. One thing changed since the last review, and it changed in the bulls' favour: sequential inflation is compressing cleanly. INDEC monthly CPI ran 3.4% in March, 2.6% in April, 2.1% in May and 1.9% in June 2026, with June core at 1.6% — the fourth consecutive deceleration. The 33.5% year-on-year headline that gets quoted is a base-effect artifact of 2025 prints rolling out, and reading it as "disinflation stalling" gets the direction backwards.

What has not changed is the tape. The ADR closed near $90.68 on 2026-07-13 (‑4.5% that session), inside the same band it has occupied since March, against a $106.15 52-week high and a $38.30 low. Nine analysts, zero holds, zero sells, consensus target $132.24 — sell-side unanimity arriving nine months after a near-3x is confirmation of a move already made. Cost of risk guided to 5.5–6% for coming quarters caps reported ROE regardless of loan growth, and the next company-specific event is the 2026-08-26 Q2 print. Between now and then the only thing that moves the thesis is the mid-August CPI release.

Bullish and bearish views on Banco Macro S.A.

The model's bull view on Banco Macro S.A. (BMA), in brief: Sequential disinflation is compounding, not stalling. The bear view: Credit quality is deteriorating faster than the headline NPL implies. Both cases follow in full.

Bull Case

  • Sequential disinflation is compounding, not stalling. MoM CPI: 3.4% (Mar) → 2.6% (Apr) → 2.1% (May) → 1.9% (Jun 2026); June core 1.6%, the softest reading of the cycle. H1 2026 accumulated 16.8%. Falling real rates are the direct transmission channel into loan demand.
  • Q1 2026 (reported 2026-05-27) earnings inflected hard. Net income Ps.139.8B, +28% QoQ and +131% YoY; net interest income Ps.975.2B, +7% QoQ / +27% YoY. EPS $1.59 beat the $1.42 consensus.
  • Runway in the loan book is structural. Argentine private-credit-to-GDP is among the lowest in the world. Management's 2026 frame — ~42% nominal loan growth, roughly 20% real loan growth, ~6% real deposit growth against ~3% GDP and ~27% inflation (2026-05-28 call) — describes multi-year re-leveraging rather than a one-quarter bounce.
  • Balance sheet is the peer-group best. Coverage 109.79% against a 5.40% NPL ratio; Macro carries lower NPLs and higher coverage than its Argentine peers and reprices provisioning more frequently into an up-cycle.
  • Cash is coming back to holders. Third installment of the cash dividend — AR$49.03B, AR$76.6883 per share — went to holders of record 2026-07-06, available from 2026-07-07. Forward yield sits near 5.8%.
  • Macro plumbing is being rebuilt. BCRA moved in 2026 to adjust the currency-band mechanism and accumulate reserves outright, reversing a long reluctance to buy dollars.

Bear Case

  • Credit quality is deteriorating faster than the headline NPL implies. Consumer NPLs went to 6.92% from 5.3%; commercial to 1.34% from 0.68% (2026-05-28 call). Management believes February was the peak — an assertion the August print either confirms or destroys.
  • Cost of risk 5.5–6% eats the loan-growth story. Provisioning at that level against ~10% annualized ROE and ~2.4% ROA means headline profitability lags the narrative for at least two more quarters.
  • Consensus expects a sequential earnings step-down. Q2 EPS estimate is $1.25 versus the $1.59 delivered in Q1. A four-quarter earnings ramp is not what the sell-side is modelling into 2026-08-26.
  • The repricing is behind the tape. The October-2025 midterm catalyst is nine months old. Four months of range-bound trade between roughly $80 and $100 while every analyst rates it Buy is distribution, not accumulation.
  • Peso translation risk sits on top of equity risk. USD/ARS pinned near 1,492 with the band ceiling in play; PIIE flagged the monetary framework as fragile in 2026. A devaluation erases operating gains for an ADR holder regardless of how the peso P&L reads.
  • The yield is not a reason to own it. A ~5.8% forward yield does not offset the 15%+ drawdown this name delivers on a single adverse CPI or FX headline.

Setup & Price Structure

Price near $90.68 (2026-07-13) sits almost exactly mid-range between the $106.15 high and the $78–82 shelf that has held every pullback since March. That is the worst location on the chart for a fresh position: no support underneath to define risk against, no breakout above to confirm. The 200-day line is still rising, so the base is intact rather than broken, but a rising long-term average with four months of sideways price is a name waiting on a catalyst it does not yet have.

Two setups would be worth acting on. A reclaim of the $100–106 shelf on expanding volume re-opens the trend and puts the $132 consensus target in play. A hold at a higher low in the $78–82 zone — the rising trendline off the September-2025 base — offers defined risk with the disinflation data still improving. Neither exists today. The sensible read on the current print is to wait, and specifically to avoid initiating into the 2026-08-26 quarter given the cost-of-risk guidance.

Catalyst Calendar (next 30 days)

  • ~2026-08-13 (est.) — INDEC national CPI for July 2026. The single thesis-moving release in the window. A fifth consecutive MoM deceleration (sub-1.9%) extends the disinflation leg; a re-acceleration above 2.1% breaks it.
  • Ongoing — BCRA currency-band adjustments and reserve accumulation reported through the month. USD/ARS near 1,492; a test of the band ceiling is the fast-moving risk.
  • 2026-08-26 — Q2 2026 earnings and call (just outside the 30-day window). Consensus EPS $1.25. The NPL trajectory and whether February was in fact the delinquency peak is what the print is actually about.
  • No scheduled company events between now and the July CPI release. The July 2026 dividend installment has already passed record date.

What Would Change Our Mind

A weekly close below $78 takes out the consolidation base and the rising 200-day line simultaneously — at that point the post-midterm structure is gone and the name is in a downtrend, not a range. On the fundamental side, two consecutive INDEC prints re-accelerating month-on-month would end the core disinflation thesis outright, as would NPLs pushing above 5.40% with coverage slipping under ~100% at the August report. A peso break through the upper currency band that forces BCRA into reserve defence would do the same damage through the FX channel regardless of what the loan book does.

Conversely, the setup upgrades on a volume reclaim of $100–106 paired with a July CPI print at or below 1.7% MoM. That combination — improving macro data plus a technical breakout — is the configuration this basket has not offered since the October-2025 leg.

Correlation Notes

BMA trades as one Argentina exposure, not as an idiosyncratic bank. It moves with GGAL, BBAR and SUPV on the same headlines; ARGT is the cleanest proxy for the basket. Sentiment beta to Milei-administration policy news and INDEC releases is high; company-specific alpha is thin outside earnings weeks. On 2026-07-07 Galicia led the Merval up 4.4% on roughly $14m turnover with the whole banking complex moving together — that is the normal pattern, and it means sizing three Argentine banks is one position taken three times. The additional layer is peso translation: local-currency operating performance and ADR performance can diverge sharply through an FX regime shift, which is a risk no amount of loan-book analysis hedges.

Notes

  • Earnings blackout: Q1 2026 printed 2026-05-27; next quarterly ~late Aug 2026 — avoid fresh entries into that print.
  • Trade as a basket with GGAL/BBAR/SUPV; ARGT ETF is the proxy. Sentiment beta high, idiosyncratic alpha low — size as one Argentina exposure.
  • Theme is maturing, not accelerating: midterm catalyst (2025-10-26) is 7+ months old and mainstream coverage (Benzinga 'World's Best Turnaround Trade', 2026-06-12) is a late-stage tell.
  • ADR carries peso translation risk on top of equity risk — a devaluation can erase operating gains.
  • Cleaner re-entry = reclaim of $100-106 shelf on volume, or higher-low hold of rising trend ~$78-82; mid-range ~$91 has no edge.
  • Earnings blackout: Q1 2026 printed 2026-05-27; next quarterly ~late Aug 2026 (Q2) — avoid fresh entries into that print.
  • Trade as a basket with GGAL/BBAR/SUPV; ARGT ETF is the proxy. High sentiment beta, low idiosyncratic alpha — size as one Argentina exposure.
  • Theme is maturing, not accelerating: the Oct-2025 midterm catalyst is 8+ months old, and the cluster of sell-side hikes (JPM $132, 2026-06-25) plus mainstream 'best turnaround trade' coverage (2026-06-12) are late-stage markers.
  • Cleaner re-entry = reclaim of the $100-106 shelf on volume, or a higher-low hold of the rising $78-82 trend; mid-range ~$90 has no edge.
  • Watch the monthly INDEC national CPI print (~mid-month) — the disinflation gauge that drives the whole Argentina basket.
  • CORRECTION to prior dossier: the 'disinflation is stalling' read was based on the YoY headline (33.5% Jun 2026), which is a base-effect artifact. Sequential MoM is decelerating cleanly — 3.4% Mar, 2.6% Apr, 2.1% May, 1.9% Jun; June core 1.6%. Track MoM, not YoY.
  • Earnings blackout: Q2 2026 reports 2026-08-26 with consensus EPS $1.25 vs $1.59 delivered in Q1 — avoid fresh entries into that print given cost-of-risk guidance of 5.5-6%.
  • Trade as a basket with GGAL/BBAR/SUPV; ARGT is the proxy. High sentiment beta, low idiosyncratic alpha — size as one Argentina exposure, not three bank positions.
  • Cleaner re-entry = reclaim of the $100-106 shelf on volume, or a higher-low hold of the rising $78-82 trend. Mid-range near $90 has no defined risk and no confirmation.
  • ADR carries peso translation risk on top of equity risk. USD/ARS ~1,492 with band-ceiling pressure; a devaluation erases peso-denominated operating gains for a dollar holder.
  • Credit-quality detail from the 2026-05-28 call: consumer NPLs 6.92% (from 5.3%), commercial 1.34% (from 0.68%), blended 5.40% with 109.79% coverage. Management claims February was the peak — the August print is the test.
  • Dividend is not the thesis. Third installment AR$49.03B / AR$76.6883 per share, record 2026-07-06; ~5.8% forward yield does not offset this name's drawdown profile.
  • Sell-side is unanimous and late: 9 buys / 0 holds / 0 sells, consensus target $132.24, arriving nine months after a near-3x off the $38.30 low.

Related · shared themes

BBAR

Banco BBVA Argentina S.A.

Argentina country trade re-accelerated: June CPI printed 1.9% MoM on 2026-07-14 (first sub-2% of the cycle) and country risk broke to 402bp, tightest since April 2018, carrying BBAR to a fresh 52-week high of $22.47. Price now sits above every published target while Q1 ROE was 8.3% — the macro is leading, the bank is lagging.

MEDIUM

SE

Sea Limited

Three-engine re-acceleration — Shopee GMV +30%, Monee loan book +71%, Garena's best quarter in 5 years — drove a Q1 beat (2026-05-12) and a +19% one-month recovery off the $77 low. Fundamentally accelerating, but the stock is short-term extended above the July 1 Bollinger break and still ~48% under its $199 high, with the Q2 print (~Aug 11) as the next binary.

MEDIUM

UGP

Ultrapar Participacoes S.A.

Brazilian fuel-distribution margin re-rate (tax-evasion crackdown) plus a live Ipiranga sale process (~R$25-30B; TotalEnergies/Aramco/J&F, BTG advising) is the leg; Q1 net income +151% YoY, sell-side confirming late (B of A upgrade 2026-07-08) into fresh 52-wk highs. 2026-08-12 Q2 print is the next test — momentum firm but PT headroom thin at $6.25 vs $6.50-7.40 targets.

MEDIUM

BAK

Braskem S.A.

Parent-level distress in the courts: ~2026-06-26 60-day São Paulo shield plus Chapter 15 in SDNY, Fitch C / S&P default (2026-06-30); management skipping ~$177M July–Aug coupons and pushing an extrajudicial plan (5-yr extension, 100% PIK) that creditors rejected while demanding shareholder burden-sharing. ADR ~$2.47 near 52-wk lows, Street PT ~$1.50, live equity-impairment tail. No momentum leg — a distressed avoid.

LOW